Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, today reported first quarter 2013 financial results and provided other general business updates.
First Quarter 2013 Financial Results
For the quarter ended March 31, 2013, Synageva reported a net loss of $14.5 million compared to a net loss of $7.4 million for the corresponding quarter of the prior year.
Help employers find you! Check out all the jobs and post your resume.
